S2k Guidelines for Cutaneous Basal Cell Carcinoma - Part 2: Treatment, Prevention and Follow-up.
Aged
Aged, 80 and over
Carcinoma, Basal Cell
/ epidemiology
Disease Management
Follow-Up Studies
Germany
/ epidemiology
Humans
Incidence
Managed Care Programs
/ standards
Middle Aged
Neoplasm Recurrence, Local
/ epidemiology
Practice Guidelines as Topic
Quality of Health Care
/ standards
Risk Assessment
Skin Neoplasms
/ epidemiology
Journal
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
ISSN: 1610-0387
Titre abrégé: J Dtsch Dermatol Ges
Pays: Germany
ID NLM: 101164708
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
entrez:
15
2
2019
pubmed:
15
2
2019
medline:
28
2
2020
Statut:
ppublish
Résumé
Basal cell carcinoma (BCC) is the most common malignant tumor among fair-skinned individuals, and its incidence had been steadily rising in the past decades. In order to maintain the highest quality of patient care possible, the German S2k guidelines were updated following a systematic literature search and with the participation of all professional societies and associations involved in the management of the disease. Part 2 addresses issues such as proper risk stratification, the various therapeutic approaches, and prevention as well as follow-up of patients with basal cell carcinoma.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
214-230Informations de copyright
© 2019 The Authors | Journal compilation © Blackwell Verlag GmbH, Berlin.